SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Alimera Sciences, Inc.
(NASDAQ : ALIM)

( )
ALIM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading ALIM News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.15%81.671.6%$916.39m
BIIBBiogen Inc.
0.00%288.351.2%$563.58m
CELGCelgene Corporation
1.29%109.501.1%$490.15m
AMGNAmgen Inc.
-0.93%169.091.2%$480.08m
REGNRegeneron Pharmaceuticals, Inc.
0.00%415.093.1%$314.35m
ALXNAlexion Pharmaceuticals, Inc.
-0.60%129.002.6%$248.70m
BMRNBioMarin Pharmaceutical Inc.
-0.09%98.003.9%$221.11m
TSROTESARO, Inc.
0.00%93.3818.0%$220.10m
ILMNIllumina, Inc.
-0.46%161.505.1%$183.80m
VRTXVertex Pharmaceuticals Incorporated
-1.42%94.651.7%$134.91m
MDVNMedivation, Inc.
0.00%62.552.6%$124.28m
JUNOJuno Therapeutics, Inc.
0.00%30.377.9%$105.68m
EXASExact Sciences Corporation
-5.17%15.9528.8%$89.97m
AAgilent Technologies, Inc.
0.00%47.271.9%$89.23m
INCYIncyte Corporation
0.00%88.722.2%$76.74m

Company Profile

Alimera Sciences, Inc. operates a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. It focuses on diseases affecting the back of the eye, or retina. Its primary product, ILUVIEN, for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficiently responsive to available therapies. Alimera Sciences was founded on June 4, 2003 by C. Daniel Myers and David R. Holland and is headquartered in Alpharetta, GA.